+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Heart Valve Repair and Replacement Devices Market 2019-2023 - Product Image

Global Heart Valve Repair and Replacement Devices Market 2019-2023

  • ID: 4764973
  • Report
  • Region: Global
  • 127 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Abbott
  • CryoLife, Inc.
  • LivaNova PLC
  • Medtronic
  • MORE
The increasing prevalence of cardiovascular diseases will drive the heart valve repair and replacement devices market growth in the forthcoming years. Disorders including the aortic stenosis, pulmonary stenosis, and a congenital heart defect have led to rising demand for heart valve repair and replacement devices. In addition, factors including tobacco abuse, high cholesterol, blood pressure, and obesity are also mainly responsible for creating a rising demand for heart valve repair and replacement devices in the long run. The analysts have predicted that the heart valve repair and replacement devices market will register a CAGR of nearly 16% by 2023.

Market Overview

Rising demand for heart valve therapies

One of the growth drivers of the global heart valve repair and replacement devices market is the rising demand for heart valve therapies. The growing incidence of heart valve diseases such as stenosis and regurgitation led to the high demand for heart valve therapies such as heart valve repair and replacement.

Shortage of cardiologists

One of the challenges in the growth of the global heart valve repair and replacement devices market is the shortage of cardiologists. Lack of expertise increases the probability of misdiagnosis and improper treatment care, which can cause harm to patients.

For the detailed list of factors that will drive and challenge the growth of the heart valve repair and replacement devices market during 2019-2023, view this report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Vendors in the market are focusing on strategies such as mergers and acquisitions, partnerships, and other developments to improve their market share and expand their presence globally. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • CryoLife, Inc.
  • LivaNova PLC
  • Medtronic
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Heart valve replacement devices - Market size and forecast 2018-2023
  • Heart valve repair devices - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: MARKET SEGMENTATION BY SURGERY
  • Market segmentation by surgery
  • Comparison by surgery
  • Minimally invasive surgeries - Market size and forecast 2018-2023
  • Transcatheter surgeries - Market size and forecast 2018-2023
  • Open surgeries - Market size and forecast 2018-2023
  • Market opportunity by surgery
PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Technological advances
  • Development of heart valve with tissue engineering approach
  • Industry developments
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Boston Scientific Corporation
  • CryoLife, Inc
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • Medtronic
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Heart valve replacement devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Heart valve replacement devices - Year-over-year growth 2019-2023 (%)
Exhibit 21: Heart valve repair devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Heart valve repair devices - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Surgery - Market share 2018-2023 (%)
Exhibit 25: Comparison by surgery
Exhibit 26: Minimally invasive surgeries - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Minimally invasive surgeries - Year-over-year growth 2019-2023 (%)
Exhibit 28: Transcatheter surgeries - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Transcatheter surgeries - Year-over-year growth 2019-2023 (%)
Exhibit 30: Open surgeries - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Open surgeries - Year-over-year growth 2019-2023 (%)
Exhibit 32: Market opportunity by surgery
Exhibit 33: Customer landscape
Exhibit 34: Market share by geography 2018-2023 (%)
Exhibit 35: Geographic comparison
Exhibit 36: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: North America - Year-over-year growth 2019-2023 (%)
Exhibit 38: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 40: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 42: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 43: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 44: Key leading countries
Exhibit 45: Market opportunity
Exhibit 46: Impact of drivers and challenges
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Abbott - Vendor overview
Exhibit 53: Abbott - Business segments
Exhibit 54: Abbott - Organizational developments
Exhibit 55: Abbott - Geographic focus
Exhibit 56: Abbott - Segment focus
Exhibit 57: Abbott - Key offerings
Exhibit 58: Boston Scientific Corporation - Vendor overview
Exhibit 59: Boston Scientific Corporation - Business segments
Exhibit 60: Boston Scientific Corporation - Organizational developments
Exhibit 61: Boston Scientific Corporation - Geographic focus
Exhibit 62: Boston Scientific Corporation - Segment focus
Exhibit 63: Boston Scientific Corporation - Key offerings
Exhibit 64: CryoLife, Inc - Vendor overview
Exhibit 65: CryoLife, Inc - Business segments
Exhibit 66: CryoLife, Inc - Organizational developments
Exhibit 67: CryoLife, Inc - Geographic focus
Exhibit 68: CryoLife, Inc - Segment focus
Exhibit 69: CryoLife, Inc - Key offerings
Exhibit 70: Edwards Lifesciences Corporation - Vendor overview
Exhibit 71: Edwards Lifesciences Corporation - Product segments
Exhibit 72: Edwards Lifesciences Corporation - Organizational developments
Exhibit 73: Edwards Lifesciences Corporation - Geographic focus
Exhibit 74: Edwards Lifesciences Corporation - Segment focus
Exhibit 75: Edwards Lifesciences Corporation - Key offerings
Exhibit 76: LivaNova PLC - Vendor overview
Exhibit 77: LivaNova PLC - Business segments
Exhibit 78: LivaNova PLC - Organizational developments
Exhibit 79: LivaNova PLC - Geographic focus
Exhibit 80: LivaNova PLC - Segment focus
Exhibit 81: LivaNova PLC - Key offerings
Exhibit 82: Medtronic - Vendor overview
Exhibit 83: Medtronic - Business segments
Exhibit 84: Medtronic - Organizational developments
Exhibit 85: Medtronic - Geographic focus
Exhibit 86: Medtronic - Segment focus
Exhibit 87: Medtronic - Key offerings
Exhibit 88: Validation techniques employed for market sizing
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott
  • CryoLife, Inc.
  • LivaNova PLC
  • Medtronic
  • MORE
Global Heart Valve Repair and Replacement Devices Market 2019-2023

The analyst recognizes the following companies as the key players in the global heart valve repair and replacement devices market: Abbott, Boston Scientific Corporation, CryoLife, Inc., Edwards Lifesciences Corporation, LivaNova PLC, and Medtronic.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the development of heart valve with a tissue engineering approach.”

According to the report, one of the major drivers for this market is the rising demand for heart valve therapies.

Further, the report states that one of the major factors hindering the growth of this market is the high cost of heart valve repair and replacement procedures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott
  • Boston Scientific Corporation
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • Medtronic
Note: Product cover images may vary from those shown
Adroll
adroll